Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
Y Liang, O Maeda, Y Ando - Japanese Journal of Clinical …, 2024 - academic.oup.com
Although immune checkpoint inhibitors have greatly improved cancer therapy, they also
cause immune-related adverse events, including a wide range of inflammatory side effects …
cause immune-related adverse events, including a wide range of inflammatory side effects …
[HTML][HTML] Development and validation of a prediction model for thyroid dysfunction in patients during immunotherapy
Q Wang, T Wu, R Zhao, Y Li, X Chen, S Shen… - Endocrine Practice, 2024 - Elsevier
Objective This study was designed to develop and validate a predictive model for assessing
the risk of thyroid toxicity following treatment with immune checkpoint inhibitors. Methods A …
the risk of thyroid toxicity following treatment with immune checkpoint inhibitors. Methods A …
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy …
L Teijeira, M Martínez, A Moreno, I de Elejoste… - Cancers, 2023 - mdpi.com
Simple Summary The growing use of immune checkpoint inhibitors (ICIs) for the treatment of
patients with solid tumors has led to a proportional increase in the incidence of toxic effects …
patients with solid tumors has led to a proportional increase in the incidence of toxic effects …
[PDF][PDF] Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor …
L Teijeira, M Martínez, A Moreno, I de Elejoste… - 2023 - pdfs.semanticscholar.org
Several factors have been associated with the occurrence of immune-related adverse
events (irAEs) induced by immune checkpoint inhibitor (ICI) therapy. Despite their …
events (irAEs) induced by immune checkpoint inhibitor (ICI) therapy. Despite their …